POLARIS Investments

Polaris Partners is a leading US-based venture capital and private equity firm founded in 1996 that specializes in early-stage through growth investments primarily within healthcare/life sciences—including biotechnology and pharma—across North America and Western Europe. The firm has funded over 400 companies with more than 100 exits and 50 IPOs. Its investment focus includes innovative care delivery models, digital health solutions/platforms for patients/providers/data analytics as well as therapeutics development. Notable recent investments include Engine Biosciences (precision medicine), Paratus Sciences (bat genomics for human disease), TRexBio (immune-mediated disease therapies), among others. The team includes experienced partners such as Brian Chee and Alexandra Cantley. Polaris operates multiple funds including its Main Fund/Growth Fund/Innovation Fund targeting both academic spinouts and established ventures.